A Study to Evaluate the Safety and Preliminary Signs of Efficacy of [177Lu]Lu-OncoFAP-23 Alone or in Combination With L19-IL2 as a Treatment of Metastatic FAP-positive Solid Tumors
Clinical trial NCT06640413 · RECRUITING
Trial details
- NCT number
- NCT06640413
- Sponsor
- Philogen S.p.A.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-31
- Primary completion
- 2028-05-31
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.